Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I.
about
The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndromeActivation of cutaneous immune responses in complex regional pain syndrome.Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: etiological contribution to complex regional pain syndromes (Part I).Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats.Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1β production in keratinocytesEndoneurial pathology of the needlestick-nerve-injury model of Complex Regional Pain Syndrome, including rats with and without pain behaviorsSubstance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome.Sex differences in a Murine Model of Complex Regional Pain Syndrome.Facilitated spinal neuropeptide signaling and upregulated inflammatory mediator expression contribute to postfracture nociceptive sensitizationmiR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression.Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.Protective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress.Mast Cell-Mediated Mechanisms of Nociception.Acute versus chronic phase mechanisms in a rat model of CRPS.Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome.Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndromeKeratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways.Replacement, refinement, and reduction: necessity of standardization and computational models for long bone fracture repair in animals.The inflammasome as a target for pain therapy.Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome.Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.Preprotachykinin-A gene disruption attenuates nociceptive sensitivity after opioid administration and incision by peripheral and spinal mechanisms in mice.Antiallodynic Effects of Bee Venom in an Animal Model of Complex Regional Pain Syndrome Type 1 (CRPS-I).Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraineKeratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute and chronic pain.Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediatorsPassive transfer autoimmunity in a mouse model of complex regional pain syndrome.The Rodent Tibia Fracture Model: A Critical Review and Comparison with the Complex Regional Pain Syndrome Literature.Neuropeptide regulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome.Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.
P2860
Q28568698-4B67E74E-AEA2-4277-B4B1-3346F3D0F067Q33573783-D0F78DD2-0817-454B-9ECF-7FAC2442B18CQ33843306-51EE6B23-E3BA-43E2-AD43-93EE897FB258Q34276067-6F038B3B-0C47-45DF-B465-286D08DE99D4Q35068859-7F717B27-33D4-4533-9DDD-67F09F06E6CDQ35223732-3E0BF541-DB91-4ED2-8CDB-5866F0D87FCBQ35850819-4477B05B-1C89-4A41-BCF1-9D1A1D1C1CCAQ35931545-03A8F672-1EC4-4845-B368-1F7F40FC74B0Q36083373-F2F46E36-7785-4A9A-9AEA-D8D87CE90F15Q36197696-DF0E68B2-D52D-42BB-8F25-FA61D69313ECQ36249124-C3AABB09-4813-48D1-BAD0-A2ABEB3A0D35Q36324486-681C813A-5FAB-42BE-A40B-B14EF8563599Q36404141-BA68276A-79B1-473D-B83A-7ED3C1C67755Q36480963-DDFA0D6B-C99F-4243-B1D0-B07FFB350E09Q36527054-3A7FA285-7AFC-48B4-9385-E1C519A2FBB6Q37020591-EDAF51B3-6AFA-43FA-88AC-66269727D207Q37237647-BAEAFAE2-24E9-4FDF-8577-AF414B003754Q38129027-B0A3C038-1F66-4167-8E0B-6674D8F4B4F6Q39036848-AB7A072F-75BB-478E-B0C2-41C06410EBF6Q39381651-87E4E656-B480-4291-80A6-16ED6BEEBB99Q39727048-24598215-4601-429A-B16A-02612257863DQ41440089-E8396E40-40B9-4D00-ACC8-35F0FD8A1A49Q41669213-C43DDA00-3B8F-4EEA-806F-AB0F9FD91559Q42180673-EA89C440-B732-4136-8BF2-2FE7245C92DFQ42181344-9C14B17A-6744-463F-A4EC-D9E16F63596AQ42382574-04314A52-C3AF-4E91-9CC6-6EC55849F7A8Q47254079-897A8B4A-29BE-46F9-8457-3A04D13BD62AQ52312548-B9DC9894-FC6A-481F-BCC3-9C8A596FBA0AQ52324612-CBBEA338-59F1-4AB0-84DE-B017AD69CC0BQ52692785-A0A601A7-9274-4687-90C0-C86C1838E729
P2860
Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Post-junctional facilitation o ...... regional pain syndrome type I.
@en
Post-junctional facilitation o ...... regional pain syndrome type I.
@nl
type
label
Post-junctional facilitation o ...... regional pain syndrome type I.
@en
Post-junctional facilitation o ...... regional pain syndrome type I.
@nl
prefLabel
Post-junctional facilitation o ...... regional pain syndrome type I.
@en
Post-junctional facilitation o ...... regional pain syndrome type I.
@nl
P2093
P2860
P1433
P1476
Post-junctional facilitation o ...... regional pain syndrome type I.
@en
P2093
Anne Louise Oaklander
David J Clark
Liping Wang
Tian-Zhi Guo
Tzuping Wei
Wade S Kingery
P2860
P304
P356
10.1016/J.PAIN.2009.04.020
P407
P577
2009-05-21T00:00:00Z